hMTH1 and GPX1 expression in human thyroid tissue is interrelated to prevent oxidative DNA damage

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Oxidative stress (OS) disrupts cellular redox balance, leading to damage like 8-oxodGTP formation.
• Human MutT homologue 1 (hMTH1) prevents genomic incorporation of 8-oxodGTP.
• Thyroid cancer cells require hMTH1 for proliferation and malignant phenotype, making it a therapeutic target.

Purpose of the Study:

• To analyze oxidative stress responses and sensitivity to hMTH1 deficiency in thyroid cancer cells.
• To investigate the role of glutathione in hMTH1-dependent thyroid cancer.
• To examine hMTH1 expression in human thyroid tumor tissues.

Main Methods:

• hMTH1 depletion using siRNA in cultured thyroid cells.
• Assessment of glutathione-dependent oxidative stress defense factors (GPX1, GCLM).
• Combination treatment with hMTH1 inhibition and glutathione synthesis inhibition.
• Analysis of hMTH1 expression in human thyroid tumor and adjacent normal tissues.

Main Results:

• hMTH1 depletion downregulated glutathione-dependent OS defense factors (GPX1, GCLM).
• Thyroid cell lines showed increased ROS burden and proliferation defects upon combined hMTH1 depletion and glutathione synthesis inhibition.
• Detailed analysis of hMTH1 expression in human thyroid tumors was performed.

Conclusions:

• hMTH1 deficiency impacts glutathione-dependent oxidative stress defense in thyroid cells.
• Combining hMTH1 suppression with agents modulating glutathione may enhance anticancer activity.
• Further research is needed to identify patient backgrounds suitable for this combination therapy.